Table 3.
Pregnancy outcomes of EAGeR cohort (n = 578 excluding 19 with missing data on mode of delivery)
| Total (n = 578) n (%) |
LDA(n = 301) n (%) |
Placebo (n = 277) n (%) |
p-Value | |
|---|---|---|---|---|
| Mode of delivery | 0.88 | |||
| Spontaneous vaginal delivery | 265 (45.9) | 135 (44.9) | 130 (46.9) | |
| Induced vaginal delivery | 157 (27.2) | 83 (27.6) | 74 (26.7) | |
| Cesarean | 156 (27.0) | 83 (27.6) | 73 (26.4) | |
| Mode of delivery by prior cesarean | ||||
| No prior cesarean delivery | 0.75 | |||
| Spontaneous vaginal delivery | 255 (52.5) | 130 (51.2) | 125 (53.9) | |
| Induced vaginal delivery | 154 (31.7) | 81 (31.9) | 73 (31.5) | |
| Cesarean | 77 (15.8) | 43 (16.9) | 34 (14.7) | |
| Prior cesarean delivery | 0.86 | |||
| Spontaneous vaginal delivery | 10 (10.9) | 5 (10.6) | 5 (11.1) | |
| Induced vaginal delivery | 3 (3.3) | 2 (4.3) | 1 (2.2) | |
| Cesarean | 79 (85.9) | 40 (85.1) | 39 (86.7) |
Abbreviations: EAGeR, effects of aspirin in gestation and reproduction; LDA, low-dose aspirin.